Oral

[O2-2] Flavi/Hepaci/Togavirus

Mon. Nov 14, 2022 4:50 PM - 5:50 PM Room 2 (Conference Room 102)

Chair:Leo Uchida(School of Veterinary Medicine, Rakuno Gakuen University), Minato Hirano(National Research Center for the Control and Prevention of Infectious Diseases, Nagasaki University)

+Add all to schedule

4:50 PM - 5:05 PM

[O2-2-13] Establishment of a cell line permissive for Norway rat hepacivirus-1 infection

*Tomohisa Tanaka¹, Naoki Ohtsu¹, Yasunori Akaike¹, Hirotake Kasai¹, Atsuya Yamashita¹, Kohji Moriishi^1,2 (1. University of Yamanashi, 2. Institute for Genetic Medicine, Hokkaido University)

5:05 PM - 5:20 PM

[O2-2-14] Identification of inhibitors of Chikungunya virus replication by In-Cell ELISA-based screen assay

*Youichi Suzuki¹, Akino Emi¹, Shoichi Sakaguchi¹, Hong Wu¹, Takashi Nakano¹ (1. Osaka Medical and Pharmaceutical University)

5:20 PM - 5:35 PM

[O2-2-15] Adaptation of rat hepacivirus in mouse and effect of its infection on liver lipogenesis

*Naoki Ohtsu¹, Tomohisa Tanaka¹, Atsuya Yamashita¹, Hirotake Kasai¹, Yasunori Akaike¹, Kohji Moriishi^1,2 (1. Yamanashi Univ., 2. Hokkaido Univ.)

5:35 PM - 5:50 PM

[O2-2-16] Development of therapeutic molecules across Blood-Brain Barrier for treatment of TBE

*Mizuki Fukuta^1,2,3, Sayo Fukano⁴, Shintaro Kobayashi⁴, Naoya Maekawa⁵, Yuji Takahashi⁴, Minato Hirano^2,3, Hiroaki Kariwa⁴, Satoru Konnai^5,6, Kentaro Yoshii^2,3,4 (1. Nagasaki University Graduate School of Biomedical Sciences, 2. National Research Center for the Control and Prevention of Infectious Diseases, Nagasaki University, 3. Institute of Tropical Medicine, Nagasaki University, 4. Laboratory of Public Health, Faculty of Veterinary Medicine, Hokkaido University, 5. Department of Advanced Pharmaceutics, Faculty of Veterinary Medicine, Hokkaido University, 6. Department of Disease Control, Faculty of Veterinary Medicine, Hokkaido University)

Session information